Accustem Sciences Inc.
ACUT· OTC
ACUTAccustem Sciences Inc.
Filed May 20, 2022 · 10-Q · 50 days after period end · 0001493152-22-014587
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Net Income | -$790.53K | -$13.87K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accustem Sciences Inc. · CIK 1850767 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 20, 2022 · 50 d after period end
